Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · March 02, 2024

Comparative Analysis of Hospitalization Risk for Incident Heart Failure in Non-Hispanic Black vs Non-Hispanic White Individuals With Type 2 Diabetes on Empagliflozin

Diabetes, Obesity & Metabolism

 

Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes, Obesity & Metabolism
Comparative analysis of hospitalization risk for incident heart failure in non-Hispanic Black versus non-Hispanic White individuals with type 2 diabetes on empagliflozin (Empa-AA): Insights from real-world data
Diabetes Obes Metab 2024 Feb 15;[EPub Ahead of Print], BM Mishriky, DM Cummings, Y Fu, JR Halladay, S Jones, AD Boan, S Jones, SP Patil, JR Powell, A Adams, W Irish

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading